| Date | Upside/Downside | Analyst Firm | Price Target Change | Rating Change | Previous / Current Rating |
|---|---|---|---|---|---|
| 11/10/2023 | -3.17% | Goldman Sachs | $16 → $18 | Maintains | Neutral |
| 10/17/2023 | -13.93% | Goldman Sachs | $25 → $16 | Downgrades | Buy → Neutral |
| 08/11/2023 | 23.72% | Barclays | $20 → $23 | Maintains | Equal-Weight |
| 07/27/2023 | 7.58% | Morgan Stanley | $24 → $20 | Maintains | Equal-Weight |
| 07/27/2023 | 34.48% | Goldman Sachs | $29 → $25 | Maintains | Buy |
| 07/27/2023 | 18.34% | Citigroup | $28 → $22 | Downgrades | Buy → Neutral |
| 07/27/2023 | 7.58% | Barclays | $23 → $20 | Maintains | Equal-Weight |
| 07/27/2023 | — | Wells Fargo | Downgrades | Overweight → Equal-Weight | |
| 05/12/2023 | 50.62% | Loop Capital | $23 → $28 | Maintains | Buy |
| 05/02/2023 | — | Barclays | Downgrades | Overweight → Equal-Weight | |
| 03/03/2023 | 50.62% | Citigroup | $48 → $28 | Maintains | Buy |
| 03/02/2023 | 29.1% | Morgan Stanley | $43 → $24 | Maintains | Equal-Weight |
| 03/02/2023 | 50.62% | Goldman Sachs | $41 → $28 | Maintains | Buy |
| 03/02/2023 | 61.38% | Wells Fargo | $44 → $30 | Maintains | Overweight |
| 03/02/2023 | 34.48% | Barclays | $43 → $25 | Maintains | Overweight |
| 01/17/2023 | — | Morgan Stanley | Downgrades | Overweight → Equal-Weight | |
| 11/15/2022 | 158.2% | Citigroup | $41 → $48 | Maintains | Buy |
| 11/14/2022 | 120.55% | Goldman Sachs | $36 → $41 | Maintains | Buy |
| 11/14/2022 | 131.31% | Barclays | $39 → $43 | Maintains | Overweight |
| 11/11/2022 | 131.31% | Morgan Stanley | $40 → $43 | Maintains | Overweight |
| 11/07/2022 | 142.07% | Jefferies | → $45 | Assumes | → Buy |
| 08/17/2022 | 109.79% | Barclays | $28 → $39 | Maintains | Overweight |
| 06/27/2022 | 72.14% | Goldman Sachs | $31 → $32 | Upgrades | Neutral → Buy |
| 06/16/2022 | 115.17% | Morgan Stanley | $65 → $40 | Maintains | Overweight |
| 05/12/2022 | 66.76% | Goldman Sachs | $41 → $31 | Maintains | Neutral |
| 03/01/2022 | 120.55% | Goldman Sachs | $48 → $41 | Maintains | Neutral |
| 03/01/2022 | 249.65% | Morgan Stanley | $70 → $65 | Maintains | Overweight |
| 11/15/2021 | 206.62% | Goldman Sachs | $59 → $57 | Downgrades | Buy → Neutral |
| 11/12/2021 | 168.96% | B of A Securities | $63 → $50 | Downgrades | Buy → Underperform |
| 10/14/2021 | 276.55% | Morgan Stanley | → $70 | Upgrades | Equal-Weight → Overweight |
| 08/27/2021 | 206.62% | Morgan Stanley | $58 → $57 | Downgrades | Overweight → Equal-Weight |
| 08/13/2021 | 174.34% | BMO Capital | $48 → $51 | Maintains | Market Perform |
| 01/20/2021 | 212% | Morgan Stanley | $48 → $58 | Maintains | Overweight |
| 11/06/2020 | 158.2% | Morgan Stanley | $37 → $48 | Maintains | Overweight |
| 10/09/2020 | 147.44% | Jefferies | $39 → $46 | Maintains | Buy |
| 08/17/2020 | 125.93% | Barclays | $40 → $42 | Maintains | Overweight |
| 08/07/2020 | 99.03% | Morgan Stanley | $34 → $37 | Maintains | Overweight |
| 07/30/2020 | 99.03% | Jefferies | $35 → $37 | Maintains | Buy |
| 05/08/2020 | 115.17% | UBS | $44 → $40 | Maintains | Buy |
| 05/08/2020 | 82.89% | Morgan Stanley | $36 → $34 | Maintains | Overweight |
| 05/08/2020 | 66.76% | Citigroup | $34 → $31 | Maintains | Buy |
| 04/17/2020 | 50.62% | Barclays | $44 → $28 | Maintains | Overweight |
| 04/09/2020 | 34.48% | Wells Fargo | $22 → $25 | Maintains | Overweight |
| 03/23/2020 | 18.34% | Wells Fargo | $42 → $22 | Maintains | Overweight |
| 03/17/2020 | 93.65% | Morgan Stanley | $40 → $36 | Maintains | Overweight |
| 02/04/2020 | 99.03% | BMO Capital | → $37 | Initiates Coverage On | → Market Perform |
| 11/13/2019 | 82.89% | Barclays | → $34 | Initiates Coverage On | → Overweight |
| 11/08/2019 | 93.65% | UBS | $35 → $36 | Maintains | Buy |
| 10/01/2019 | — | B of A Securities | Upgrades | Neutral → Buy | |
| 09/30/2019 | 61.38% | Wells Fargo | $37 → $30 | Maintains | Outperform |
| 08/07/2019 | 99.03% | Loop Capital | $30 → $37 | Upgrades | Hold → Buy |
| 07/11/2019 | 77.51% | Goldman Sachs | → $33 | Initiates Coverage On | → Buy |
| 06/14/2019 | 39.86% | Loop Capital | → $26 | Initiates Coverage On | → Hold |
| 05/29/2019 | 104.41% | Berenberg | → $38 | Initiates Coverage On | → Buy |
| 11/15/2018 | 163.58% | Citigroup | $51 → $49 | Maintains | Buy |
What is the target price for National Vision Holdings (EYE)?
The latest price target for National Vision Holdings (NASDAQ: EYE) was reported by Goldman Sachs on November 10, 2023. The analyst firm set a price target for $18.00 expecting EYE to fall to within 12 months (a possible -3.17% downside). 20 analyst firms have reported ratings in the last year.
What is the most recent analyst rating for National Vision Holdings (EYE)?
The latest analyst rating for National Vision Holdings (NASDAQ: EYE) was provided by Goldman Sachs, and National Vision Holdings maintained their neutral rating.
When is the next analyst rating going to be posted or updated for National Vision Holdings (EYE)?
Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of National Vision Holdings, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for National Vision Holdings was filed on November 10, 2023 so you should expect the next rating to be made available sometime around November 10, 2024.
Is the Analyst Rating National Vision Holdings (EYE) correct?
While ratings are subjective and will change, the latest National Vision Holdings (EYE) rating was a maintained with a price target of $16.00 to $18.00. The current price National Vision Holdings (EYE) is trading at is $18.59, which is out of the analyst's predicted range.